Compare CLDX & HAYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLDX | HAYW |
|---|---|---|
| Founded | N/A | 1925 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Electronic Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.1B |
| IPO Year | 1995 | 2021 |
| Metric | CLDX | HAYW |
|---|---|---|
| Price | $38.43 | $12.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 3 |
| Target Price | ★ $46.60 | $17.50 |
| AVG Volume (30 Days) | 678.9K | ★ 2.0M |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 25.93 |
| EPS | N/A | ★ 0.11 |
| Revenue | $12,743,000.00 | ★ $1,122,155,000.00 |
| Revenue This Year | $111.39 | $6.22 |
| Revenue Next Year | $235.85 | $5.96 |
| P/E Ratio | ★ N/A | $115.91 |
| Revenue Growth | ★ 87.78 | 6.71 |
| 52 Week Low | $22.10 | $12.84 |
| 52 Week High | $45.14 | $17.73 |
| Indicator | CLDX | HAYW |
|---|---|---|
| Relative Strength Index (RSI) | 45.97 | 28.42 |
| Support Level | $28.51 | N/A |
| Resistance Level | $40.30 | $17.21 |
| Average True Range (ATR) | 1.37 | 0.33 |
| MACD | -0.29 | -0.11 |
| Stochastic Oscillator | 31.63 | 5.88 |
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.1 billion in revenue in 2025.